Ferrari, Silvia Martina

Hashimotos' thyroiditis: epidemiology, pathogenesis, clinic and therapy

Ragusa, F., Fallahi, P., Elia, G., Gonnella, D., Paparo, S. R., Giusti, C., Churilov, L. P., Ferrari, S. M., & Antonelli, A. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 655

Chemokine (C–X–C motif) ligand (CXCL)10 in autoimmune diseases

Antonelli, A., Ferrari, S. M., Giuggioli, D., Ferrannini, E., Ferri, C., & Fallahi, P. (2014) · Autoimmunity Reviews

Chemokine receptors and signalinginterferon and immune responses

Cited by 595

Autoimmune endocrine dysfunctions associated with cancer immunotherapies

Ferrari, S. M., Fallahi, P., Elia, G., Ragusa, F., Ruffilli, I., Patrizio, A., Galdiero, M. R., Baldini, E., Ulisse, S., Marone, G., et al. (2019) · International Journal of Molecular Sciences

Cancer Immunotherapy and BiomarkersAdrenal Hormones and Disorders

Cited by 107

TSH normalization in bariatric surgery patients after the switch from L-Thyroxine in tablet to an oral liquid formulation

Fallahi, P., Ferrari, S. M., Camastra, S., Politti, U., Ruffilli, I., Vita, R., Navarra, G., Benvenga, S., & Antonelli, A. (2017) · Obesity Surgery

Bariatric Surgery and OutcomesThyroid Disorders and Treatments

Cited by 81

Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer

Antonelli, A., Bocci, G., La Motta, C., Ferrari, S. M., Fallahi, P., Fioravanti, A., Sartini, S., Minuto, M., Piaggi, S., Corti, A., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Cancer Diagnosis and TreatmentHeterocyclic Compound Synthesis and Bioactivity

Cited by 66

Thyroid dysfunctions induced by tyrosine kinase inhibitors

Fallahi, P., Ferrari, S. M., Vita, R., Di Domenicantonio, A., Corrado, A., Benvenga, S., & Antonelli, A. (2014) · Expert Opinion on Drug Safety

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 60

Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study

Fallahi, P., Ferrari, S. M., & Antonelli, A. (2016) · Endocrine

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 53

Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series

Fallahi, P., Ferrari, S. M., Ruffilli, I., & Antonelli, A. (2016) · BMC Gastroenterology

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 46

Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine

Fallahi, P., Ferrari, S. M., Marchi, S., De Bortoli, N., Ruffilli, I., & Antonelli, A. (2017) · Endocrine

Thyroid Disorders and TreatmentsDigestive system and related health

Cited by 31

Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy

Ferrari, S. M., Ragusa, F., Paparo, S. R., Nasini, F., Nardi, M., Franceschini, S. S., Fallahi, P., & Antonelli, A. (2019) · Autoimmunity Reviews

Ophthalmology and Eye DisordersChemokine receptors and signaling

Cited by 26

Increased requirement of replacement doses of levothyroxine caused by liver cirrhosis.

Benvenga, S., Capodicasa, G., Perelli, S., Ferrari, S. M., Fallahi, P., & Antonelli, A. (2018) · Frontiers in Endocrinology

Thyroid Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 25